Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective...

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Pharmacology

Background:

• Bacterial endocarditis is a serious infection requiring effective antimicrobial therapy.
• Predicting treatment outcomes in endocarditis is crucial for patient management.
• The utility of serum bactericidal tests (SBTs) in guiding endocarditis therapy remains debated.

Purpose of the Study:

• To evaluate the predictive accuracy of a standardized serum bactericidal test for bacterial endocarditis outcomes.
• To determine optimal serum bactericidal titer thresholds for predicting treatment success.

Main Methods:

• A multicenter collaborative study involving 129 bacterial endocarditis patients.
• Standardized microdilution method for serum bactericidal testing with defined variables.
• Correlation of peak and trough serum bactericidal titers with bacteriologic cure and clinical outcome.

Main Results:

• Peak serum bactericidal titers ≥1:64 and trough titers ≥1:32 accurately predicted bacteriologic cure.
• The traditional recommendation of a 1:8 titer showed predictive accuracy only at trough levels.
• The SBT was a poor predictor of bacteriologic failure and overall clinical outcome.

Conclusions:

• Standardized serum bactericidal testing can reliably predict bacteriologic success in endocarditis.
• Higher SBT thresholds (peak ≥1:64, trough ≥1:32) are recommended for optimal therapy.
• Physicians and microbiologists should recognize the limitations of SBTs in predicting treatment failure and clinical outcomes.